scispace - formally typeset
D

David Ortega-Alarcon

Researcher at University of Zaragoza

Publications -  19
Citations -  291

David Ortega-Alarcon is an academic researcher from University of Zaragoza. The author has contributed to research in topics: Chemistry & Biology. The author has an hindex of 4, co-authored 12 publications receiving 118 citations.

Papers
More filters
Journal ArticleDOI

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.

TL;DR: Quercetin, with well-known pharmacokinetic and ADMET properties, can be considered as a good candidate for further optimization and development, or repositioned for COVID-19 therapeutic treatment.
Journal ArticleDOI

Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs

TL;DR: In this article, the authors used rutin, a natural flavonoid that is the most common glycosylated conjugate of quercetin, as a model combining experimental (spectroscopy and calorimetry) and simulation techniques (docking and molecular dynamics simulations).
Journal ArticleDOI

Reproducibility and accuracy of microscale thermophoresis in the NanoTemper Monolith: a multi laboratory benchmark study

TL;DR: This study characterized the instrument properties and evaluated instrument performance, reproducibility, the effect of different analysis tools, the influence of the experimenter during data analysis, and thus the overall reliability of this method.
Journal ArticleDOI

Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds.

TL;DR: In this paper, the natural compound eugenol is shown to be able to hamper the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (Ki = 0.81 μM).